e-Therapeutics Appoints Daniel Elger as Chief Financial Officer
e-Therapeutics plc announced that Dr Daniel Elger will be joining the Company and its Board as Chief Financial Officer, with immediate effect.
Dr Elger, 41, was previously the VP, Marketing & Communications at cancer drug developer Antisoma plc. He joined that company in 2002 and served on its Senior Management Team from 2005, playing significant roles in corporate strategy, fundraisings and the acquisition of two US biotech companies. He also directed the investor relations strategy for the Company. Before Antisoma, Daniel was a Programme Director for major pharmaceutical companies at a leading marketing and communications agency. He holds a BA in Physiological Sciences (Medicine) and a PhD in cancer cell biology, both from Oxford University.
Most read news
Organizations
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.